| Mrs Rachel Elizabeth Gonzalez, PHARMD | |
|
430 W Main St Apt 204, Madison, WI 53703-3182 | |
| (608) 251-2930 | |
| Not Available |
| Full Name | Mrs Rachel Elizabeth Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 430 W Main St Apt 204, Madison, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003099763 | NPI | - | NPPES |
| 14363-40 | Other | WI | PHARMACIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14363-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rachel Elizabeth Gonzalez, PHARMD 430 W Main St Apt 204, Madison, WI 53703-3182 Ph: (608) 251-2930 | Mrs Rachel Elizabeth Gonzalez, PHARMD 430 W Main St Apt 204, Madison, WI 53703-3182 Ph: (608) 251-2930 |
News Archive
Metabolic complications of obesity and overweight, such as type 2 diabetes, are an important challenge to public health. Teams led by Nicolas Venteclef, Inserm Research Fellow (Cordeliers Research Centre, Inserm/Pierre and Marie Curie University Joint Research Unit 1138, Paris, France) and Irina Udalova (Kennedy Institute of Rheumatology, University of Oxford, UK) in collaboration with several teams, have succeeded in elucidating part of the mechanisms involved in the development of these metabolic complications associated with obesity.
According to a new U.S. study of 1014 adolescents who were 13 to 16 years of age, almost 11 percent had suffered from insomnia at some stage.
Members of the fiscally conservative, Democratic Blue Dog Coalition on Monday sent a letter to the chairs of three House committees who have been tasked with drafting health care legislation, saying they are "increasingly troubled" by the exclusivity of the process, the New York Times reports.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
Cardiovascular diseases (CVD) are major contributors to morbidity and mortality worldwide.
› Verified 5 days ago
Jason Alan Christensen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Compliance Mail Code 2433, Madison, WI 53792 Phone: 608-662-0817 | |
Dr. Mindy Bauer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 752 N High Point Rd, Madison, WI 53717 Phone: 608-824-4500 Fax: 608-824-4928 | |
Dr. Maria Charmaine Wopat, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 608-256-1901 | |
Rosmery Cuya, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3710 E Washington Ave, Madison, WI 53704 Phone: 608-257-0804 | |
Ms. Lauren M Mcginty, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Avenue, University Of Wisconsin Hospital And Clinics, Madison, WI 53792 Phone: 608-263-1290 Fax: 608-263-9424 | |
Elaine Constance Taylor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Compliance Mail Code 2433, Madison, WI 53792 Phone: 608-662-0817 |